Table 1

Number of incident lymphoma cases by WHO subtype in Manitoba, Canada (1984–2013)

Lymphoma classification	Men			Women			p Value for median age comparison
Lymphoma classification	N	Median age	%	N	Median age	%	p Value for median age comparison
Lymphoid neoplasms	6808	67	100.0	5520	71	100.0	<0.0001
Hodgkin lymphoma (HL)	418	41	6.1	320	37	5.8	0.270
Classical Hodgkin lymphoma	393	41	5.8	312	37	5.7	0.221
Nodular lymphocyte predominant HL	25	45	0.4	8	51	0.1	0.313
Non-Hodgkin lymphoma (NHL)	5971	68	87.7	4783	71	86.6	<0.0001
Precursor NHL, B cell and T cell	101	47	1.5	72	58	1.3	0.020
Mature NHL, B cell	5430	68	79.8	4374	71	79.2	<0.0001
Chronic/small/prolymphocytic/mantle B cell NHL	1772	70	26.0	1184	73	21.4	<0.0001
Chronic/small lymphocytic leukaemia/lymphoma	1635	70	24.0	1103	73	20.0	<0.0001
Prolymphocytic leukaemia, B cell	S	52	0.0	S	81	0.0	0.317
Mantle cell lymphoma	134	69	2.0	80	72	1.4	0.012
Lymphoplasmacytic lymphoma/Waldenstrom	179	70	2.6	130	73	2.4	0.110
Lymphoplasmacytic lymphoma	34	69	0.5	28	72	0.5	0.197
Waldenstrom macroglobulinaemia	145	71	2.1	102	75	1.8	0.102
Diffuse large B cell lymphoma	1092	67	16.0	1012	71	18.3	<0.0001
Burkitt lymphoma/leukaemia	36	48	0.5	21	64	0.4	0.092
Marginal zone lymphoma	244	68	3.6	222	70	4.0	0.155
Follicular lymphoma	761	61	11.2	745	64	13.5	<0.0001
Hairy cell leukaemia	94	61	1.4	29	58	0.5	0.395
Plasma cell neoplasms	1136	71	16.7	921	75	16.7	<0.0001
NHL, B cell, NOS	116	73	1.7	110	76	2.0	0.316
Mature NHL, T cell	268	63	3.9	189	67	3.4	0.005
Mycosis fungoides/Sezary syndrome	90	63	1.3	61	65	1.1	0.120
Peripheral T cell lymphoma	145	63	2.1	105	67	1.9	0.078
Other NK/T cell and T cell NOS	33	63	0.5	23	73	0.4	0.178
NHL, unknown lineage	172	70	2.5	148	70	2.7	0.852
Composite HL and NHL	S	53	0.0	S	66	0.0	0.157
Lymphoid neoplasm, NOS	417	72	6.1	416	76	7.5	<0.0001